A decisional algorithm to start iron chelation in patients with beta thalassemia

Haematologica

Volumn 99, Issue 3, 2014, Pages

  Danjou, Fabrice ^a   Cabantchik, Zvi Ioav ^b   Origa, Raffaella ^a   Moi, Paolo ^a   Marcias, Michela ^c   Barella, Susanna ^d   Defraia, Elisabetta ^d   Dessì, Carlo ^d   Foschini, Maria Loreta ^d   Giagu, Nicolina ^d   Leoni, Giovan Battista ^d   Morittu, Maddalena ^d   Galanello, Renzo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d Osp Regionale per le Microcitemie   (Italy)

Author keywords

Iron chelation; Percentage transferrin saturation; RBC; Start; Thalassemia major

Indexed keywords

FERRITIN; IRON; IRON CHELATING AGENT;

ALGORITHM; BETA THALASSEMIA; CHELATION THERAPY; CHEMILUMINESCENCE IMMUNOASSAY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; ERYTHROCYTE TRANSFUSION; HUMAN; INFANT; IRON CHELATION; LETTER; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; BETA-THALASSEMIA; BLOOD; COMPLICATION; IRON OVERLOAD;

ALGORITHMS; BETA-THALASSEMIA; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; HUMANS; INFANT; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; ROC CURVE;

EID: 84895757736     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.098202     Document Type: Letter

References (14)

1. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007;92(5):583-8.
2. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2006;8(3):543-7.
3. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001; 22(23):2171-9.
4. Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, et al. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol. 2006;28(5):311-5.
5. Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood. 1996;88(2):705-13.
6. Cabantchik ZI, Kakhlon O, Epsztejn S, Zanninelli G, Breuer W. Intracellular and extracellular labile iron pools. Adv Exp Med Biol. 2002;509:55-75.
7. Breuer W, Ghoti H, Shattat A, Goldfarb A, Koren A, Levin C, et al. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients. Am J Hematol. 2012;87(1):55-61.
8. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005; 18(2):277-87.
9. Sohn YS, Ghoti H, Breuer W, Rachmilewitz E, Attar S, Weiss G, Cabantchik ZI. The role of endocytic pathways in cellular uptake of plasma non-transferrin iron. Haematologica. 2012;97(5):670-8.
10. Cabantchik ZI, Sohn Y-S, Breuer W, Espósito BP. The molecular and cellular basis of iron toxicity in Iron Overload (IO) disorders. Diagnostic and therapeutic approaches. A review. Thalassemia Rep. 2013;3(s1):e3
11. Cabantchik ZI, Fibach E, Bruer W. Can labile plasma iron (LPI) and labile cell iron (LCI) levels serve as early indicators of chelation efficacy in iron overload? Blood Med. com.2009. Available from: http://www.bloodmed.com/800000/mini-reviews1.asp?id=254
12. Zanninelli G, Breuer W, Cabantchik ZI. Daily labile plasma iron as an indicator of chelator activity in Thalassaemia major patients. Br J Haematol. 2009;147(5):744-51.
13. Pootrakul P, Breuer W, Sametband M, Sirankapracha P, Hershko C, Cabantchik ZI. Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator. Blood. 2004;104(5):1504-10.
14. Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, et al. High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol. 2009;84(1):29-33.